Adherium (ADR.AX) Azione Prezzo

Adherium Ltd. engages in the development, manufacture, and supply of connected medical devices and respiratory medications used by patients, pharmaceutical companies, healthcare providers, and contract research organizations. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-26. The firm is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Company’s Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Company’s technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.